v3.26.1
LONG-TERM DEBT (Tables)
 12 Months Ended
Aug. 01, 2026
Debt Disclosure [Abstract]  
Schedule of Long-Term Debt
The Company’s long-term debt consisted of the following:
(in millions)
Average Interest Rate at
August 1, 2026
Fiscal Maturity YearAugust 1, 2026August 2, 2025
Term Loan Facility (1)
7.73%2031$370 $383 
ABL Credit Facility (2)
4.98%2031863 999 
Senior Notes (3)
6.75%2029350 500 
Debt issuance costs, net(15)(13)
Original issue discount on debt(5)(7)
Long-term debt, including current portion1,563 1,862 
Less: current portion of long-term debt(2)(3)
Long-term debt$1,561 $1,859 
(1) Face value before debt issuance costs of $5 million and $4 million, respectively and an original issue discount on debt of $5 million and $7 million, respectively.
(2) Face value before debt issuance costs of $8 million and $5 million, respectively.
(3) Face value before debt issuance costs of $2 million and $4 million, respectively.
Schedule of Maturities of Long-Term Debt
Future maturities of long-term debt, excluding debt issuance costs and original issue and purchase accounting discounts on debt, and contractual interest payments based on the face value and applicable interest rate as of August 1, 2026, consist of the following (in millions):
Fiscal YearLong-term debt maturityInterest on long-term debt
2027$4 $96 
20284 96 
2029354 84 
20304 73 
20311,217 48 
$1,583 $397 
Schedule of Line of Credit Facilities The applicable margins and letter of credit fees under the ABL Credit Facility are variable and are dependent upon the prior fiscal quarter’s daily average Availability (as defined in the ABL Loan Agreement), and were as follows:
Range of Facility Rates and Fees (per annum)August 1, 2026
Applicable margin for revolver base rate loans
0.125% - 0.375%
0.125 %
Applicable margin for revolver SOFR and BA loans(1)
1.125% - 1.375%
1.125 %
Applicable margin for FILO base rate loans
1.00% - 1.25%
1.00 %
Applicable margin for FILO SOFR loans
2.00% - 2.25%
2.00 %
Unutilized commitment fees
0.20%
0.20 %
Letter of credit fees
1.25% - 1.50%
1.25 %
(1) The Company utilizes SOFR-based loans and UNFI Canada utilizes bankers’ acceptance rate-based loans.
The assets included in the Consolidated Balance Sheets securing the outstanding obligations under the ABL Credit Facility on a first-priority basis were as follows:
(in millions)August 1, 2026August 2, 2025
Certain inventory assets included in Inventories, net $1,653 $1,830 
Certain receivables included in Accounts receivable, net 630 780 
Pharmacy prescription files included in Intangible assets, net— 1 
Total $2,283 $2,611 
The Company’s unused credit under the ABL Credit Facility was as follows:
(in millions)August 1, 2026
Total availability for ABL loans and letters of credit$2,293 
ABL loans outstanding863 
Letters of credit outstanding199 
Unused credit$1,231